Navigating the Potential of Combination Studies & Oncolytic Viruses for Improved Therapeutic Outcomes

Time: 2:30 pm
day: Pre-Conference Day


  • Innovative combinations of oncolytic viruses with other therapeutic modalities 
  • Leveraging the immune system with immune checkpoint inhibitors, vaccines, and immune stimulators 
  • Targeting tumor microenvironment and immune evasion mechanisms for enhanced efficacy 
  • Examples of preclinical and clinical studies demonstrating enhanced antitumor efficacy